Neuroleptic malignant syndrome: Difference between revisions
(Created page with "==Pathogenesis== Related to Dopamine Blockade in: Anterior Hypothalamus --> Hyperthermia Frontal Lobe --> AMS Nigrostriatal Pathways --> Rigidity Sympathetic Nervous System...") |
No edit summary |
||
| Line 1: | Line 1: | ||
== | ==Background== | ||
Related to Dopamine Blockade in: | Related to Dopamine Blockade in: | ||
#Anterior Hypothalamus --> Hyperthermia | |||
#Frontal Lobe --> AMS | |||
#Nigrostriatal Pathways --> Rigidity | |||
#Sympathetic Nervous System --> Autonomic Instability | |||
===Potential Pitfalls=== | |||
#Overlooking the AMS in a “psych pt” | |||
#Delay in obtaining rectal temp | |||
#Use of physical restraints | |||
#Isometric contractions leads increased metabolism, worsening rhabdo and hyperthermia | |||
#Use of high potency antipsychotics in the ER | |||
==Diagnosis== | ==Diagnosis== | ||
Classic Tetrad of Symptoms: | Classic Tetrad of Symptoms: | ||
# Altered Mental Status | |||
# Muscular Rigidity | |||
# Fever | |||
# Autonomic Instability | |||
===Clinical History=== | |||
Clinical History | |||
Drug Exposure: | Drug Exposure: | ||
#Typical high potency antipsychotics (haloperidol) | |||
#Atypical neuroleptics (risperidone, olanzapine, clozapine) | |||
#Antiemetics (metochlopromide, promethazine) | |||
#Withdrawal of anti-Parkinson medication | |||
Timing: | Timing: | ||
#Symptoms typically occur within 4-14d following initiation of med or an increase in dosing; can occur years after initiating therapy | |||
Laboratory Examination (non-specific): | Laboratory Examination (non-specific): | ||
#Total CK > 1000 | |||
#WBC > 10K | |||
#Mildly elevated LDH, LFTs | |||
#Renal Insufficiency | |||
#CSF with mildly elevated Protein | |||
#Low Serum Iron | |||
Diagnostic Criteria: | Diagnostic Criteria: | ||
DSM-IV: | DSM-IV: | ||
#Recent administration of antipsychotic | |||
#Elevated Temp (> 40C) | |||
#Muscle Rigidity | |||
#Atleast 2 other signs/symptoms or lab findings c/w NMS | |||
==DDx== | |||
#Delirium tremens | |||
#Heat Stroke (altered CNS, temp >40) | |||
#Meningitis | |||
#Malignant Hyperthermia (genetic d/o; 1h post general anesthetic; hyperthermia up to 45deg C, rigidity, tachy, skin cyanosis with mottling) | |||
DDx | |||
Delirium tremens | |||
Heat Stroke (altered CNS, temp >40) | |||
Meningitis | |||
Malignant Hyperthermia (genetic d/o; 1h post general anesthetic; hyperthermia up to 45deg C, rigidity, tachy, skin cyanosis with mottling) | |||
==Treatment== | ==Treatment== | ||
#ABCs | |||
#Stop the Offending Agent | |||
ABCs | #Aggressive Cooling Measures | ||
#Fluid Resuscitation | |||
Stop the Offending Agent | #Supportive Care | ||
#Benzos: for agitation | |||
Aggressive Cooling Measures | #Dantrolene: | ||
##direct skeletal muscle relaxant | |||
Fluid Resuscitation | ##(Showed improvement in 80% cases) | ||
##Dosage: 10mg/kg per day | |||
Supportive Care | ##Relative Contraindication in pts on CCB (can lead to cardiovascular collapse) | ||
#Bromocriptine: | |||
Benzos: for agitation | ##dopamine agonist to counteract central blockade | ||
##Max: 40mg/day | |||
#Amantadine: | |||
##dopamine agonist and anticholinergic agent | |||
Dantrolene: | ##Max 400mg/day | ||
#Consider ECT | |||
direct skeletal muscle relaxant | |||
(Showed improvement in 80% cases) | |||
Dosage: 10mg/kg per day | |||
Relative Contraindication in pts on CCB (can lead to cardiovascular collapse) | |||
Bromocriptine: | |||
dopamine agonist to counteract central blockade | |||
Max: 40mg/day | |||
Amantadine: | |||
dopamine agonist and anticholinergic agent | |||
Max 400mg/day | |||
Consider ECT | |||
Retrospective analysis: suggests pts on dantrolene +/- bromocriptine have a faster recovery (9days vs 12Days) | Retrospective analysis: suggests pts on dantrolene +/- bromocriptine have a faster recovery (9days vs 12Days) | ||
==Woodbury Stages== | |||
Woodbury Stages | |||
Incorporates severity of disease with treatment | Incorporates severity of disease with treatment | ||
(I-III: supportive care +/- benzos) | #(I-III: supportive care +/- benzos) | ||
#Stage IV (Moderate NMS): All four features present | |||
##TX: benzos, bromocriptine | |||
#Stage V (Severe NMS) Tetrad with more severe hyperthermia | |||
Stage IV (Moderate NMS): All four features present | ##TX: benzos, dantrolene, bromocriptine, consider ECT | ||
TX: benzos, bromocriptine | |||
Stage V (Severe NMS) Tetrad with more severe hyperthermia | |||
TX: benzos, dantrolene, bromocriptine, consider ECT | |||
==Complications== | ==Complications== | ||
arrhthmias, renal failure, seizures, pneumonia, DIC, death | arrhthmias, renal failure, seizures, pneumonia, DIC, death | ||
===Prognosis=== | |||
Prognosis== | |||
Most resolve within 2 weeks, without long term sequelae | Most resolve within 2 weeks, without long term sequelae | ||
Poorer prognosis in those with high peak and/or long duration of hyperthermia | Poorer prognosis in those with high peak and/or long duration of hyperthermia | ||
Mortality of 10-20% | |||
==Source== | ==Source== | ||
Pani 6/2009 based on Rosen's | Pani 6/2009 based on Rosen's | ||
[[Category:Neuro]] | [[Category:Neuro]] | ||
Revision as of 07:44, 28 March 2011
Background
Related to Dopamine Blockade in:
- Anterior Hypothalamus --> Hyperthermia
- Frontal Lobe --> AMS
- Nigrostriatal Pathways --> Rigidity
- Sympathetic Nervous System --> Autonomic Instability
Potential Pitfalls
- Overlooking the AMS in a “psych pt”
- Delay in obtaining rectal temp
- Use of physical restraints
- Isometric contractions leads increased metabolism, worsening rhabdo and hyperthermia
- Use of high potency antipsychotics in the ER
Diagnosis
Classic Tetrad of Symptoms:
- Altered Mental Status
- Muscular Rigidity
- Fever
- Autonomic Instability
Clinical History
Drug Exposure:
- Typical high potency antipsychotics (haloperidol)
- Atypical neuroleptics (risperidone, olanzapine, clozapine)
- Antiemetics (metochlopromide, promethazine)
- Withdrawal of anti-Parkinson medication
Timing:
- Symptoms typically occur within 4-14d following initiation of med or an increase in dosing; can occur years after initiating therapy
Laboratory Examination (non-specific):
- Total CK > 1000
- WBC > 10K
- Mildly elevated LDH, LFTs
- Renal Insufficiency
- CSF with mildly elevated Protein
- Low Serum Iron
Diagnostic Criteria:
DSM-IV:
- Recent administration of antipsychotic
- Elevated Temp (> 40C)
- Muscle Rigidity
- Atleast 2 other signs/symptoms or lab findings c/w NMS
DDx
- Delirium tremens
- Heat Stroke (altered CNS, temp >40)
- Meningitis
- Malignant Hyperthermia (genetic d/o; 1h post general anesthetic; hyperthermia up to 45deg C, rigidity, tachy, skin cyanosis with mottling)
Treatment
- ABCs
- Stop the Offending Agent
- Aggressive Cooling Measures
- Fluid Resuscitation
- Supportive Care
- Benzos: for agitation
- Dantrolene:
- direct skeletal muscle relaxant
- (Showed improvement in 80% cases)
- Dosage: 10mg/kg per day
- Relative Contraindication in pts on CCB (can lead to cardiovascular collapse)
- Bromocriptine:
- dopamine agonist to counteract central blockade
- Max: 40mg/day
- Amantadine:
- dopamine agonist and anticholinergic agent
- Max 400mg/day
- Consider ECT
Retrospective analysis: suggests pts on dantrolene +/- bromocriptine have a faster recovery (9days vs 12Days)
Woodbury Stages
Incorporates severity of disease with treatment
- (I-III: supportive care +/- benzos)
- Stage IV (Moderate NMS): All four features present
- TX: benzos, bromocriptine
- Stage V (Severe NMS) Tetrad with more severe hyperthermia
- TX: benzos, dantrolene, bromocriptine, consider ECT
Complications
arrhthmias, renal failure, seizures, pneumonia, DIC, death
Prognosis
Most resolve within 2 weeks, without long term sequelae
Poorer prognosis in those with high peak and/or long duration of hyperthermia
Mortality of 10-20%
Source
Pani 6/2009 based on Rosen's
